Some researchers argue that amyloid beta (Aβ) precursor molecules can aggregate into many different forms of soluble oligomers—as can the tau proteins—and that there is still a lot of work to be done understanding how these all relate to AD progression. This evidence concerns the gene MAPT and Alzheimer disease.